← Back to patent-cliff list

CAS 1191-99-7

2,3-dihydrofuran

Codes: DARU-001, CEBR-008

Application context (from source-drug indications)

HIV infectionDarunavir Ethanolate/RitonavirHIV infectionDarunavir Ethanolate/CobicistatHIV infectionDarunavir EthanolatePainCebranopadol hemicitrate急性疼痛Cebranopadol hemicitrate神经痛Cebranopadol hemicitrateLow back painCebranopadol hemicitrateSubstance-related disorderCebranopadol hemicitrateChronic painCebranopadol hemicitrate

Source drugs (routes using this intermediate)

DrugTierExpiry
Darunavir Ethanolate/RitonavirTier C — Watch / trade-
Darunavir Ethanolate/CobicistatTier C — Watch / trade-
Darunavir EthanolateTier B — Position early-
Cebranopadol hemicitrateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Cebranopadol hemicitrateOriginator routesteps: 6total yield: 640mg

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.